1. In-vitro stimulation of neutrophil motility by levamisole: maintenance of cGMP levels in chemotactically stimulated levamisole-treated neutrophils;Anderson, R.; Glover, A.M.; Koornhof, H.J.; Rabson, A.R.;Journal of Immunology,1976
2. In-vitro restoration by levamisole of thymus-derived lymphocyte function in Hodgkin's disease;Biniaminov, M.; Ramot, B.;Lancet,1975
3. Modulation of inflammation and immunity by cyclic AMP;Bourne, H.R.; Lichtenstein, L.M.; Melmon, K.L.; Henney, C.S.; Weinstein, Y.; Shearer, G.M.;Science,1974
4. Extreme hyperimmunoglobulinemia E and undue susceptibility to infection;Buckley, R.H.; Wray, B.B.; Belmaker, E.Z.;Pediatrics,1972
5. Defective neutrophil chemotaxis and cellular immunity in a child with recurrent infections;Clark, R.A.; Root, R.K.; Kimball, H.R.; Kirkpatrick, C.M.;Annals of Internal Medicine,1973